NEUROTOXINS AND DRUGS FOR THE TREATMENT OF PARKINSON'S DISEASE. PART I : NEUROTOXINS, LEVODOPA, AND AGENTS INFLUENCING DOPAMINE METABOLISM (A REVIEW)
SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF NEW 2-[(2-PHTHALIMIDOETHYL)THIO]-4(3H)-PYRIMIDINONE DERIVATIVES
SYNTHESIS AND ANTITUMOR ACTIVITY OF 2-S-SUBSTITUTED PYRIMIDINE DERIVATIVES
SYNTHESIS AND ANTICHOLINESTERASE ACTIVITY OF N-OXYALKYL-SUBSTITUTED PYRIDINIUM AND HYDROQUINOLINIUM SALTS AND THEIR ISOLOGS
SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 2-METHOXYPHENYL-SUBSTITUTED 9-DIALKYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLES
SYNTHESIS AND ANTIINFLAMMATORY AND ANALGESIC ACTIVITY OF 1-(2-AMINOETHYL)-5-ARYL-4-ACYL-3-HYDROXY-3-PYRROLIN-2-ONES
STRUCTURAL FEATURES OF THE BINDING SITE FOR DIPHENIN AND OTHER ANTICONVULSANTS BELONGING TO THE GROUP OF SODIUM CHANNEL BLOCKERS
AUXILIARY SUBSTANCES USED IN TECHNOLOGY OF SOFT MEDICINAL FORMS : OINTMENTS, GELS, LINIMENTS, AND CREAMS (A REVIEW)
INVESTIGATIONS INTO THE TECHNOLOGY OF VITAMIN B1 : OPTIMIZATION OF THE SYNTHESIS OF 4-METHYL-5-(β-ACETOXYETHYL)THIAZOLE
AZACYCLOALKANES. XXXVII1 : 3,4-DIHYDRO-5H-PYRROLO[1,2-A]-DIAZEPINE AND ITS CONVERSIONS